(Q36416737)

14 August 2017

Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate (English)

1 reference

cost-effectiveness analysis

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

Hormone Replacement Therapy

1 reference

4

Deborah A Galuska

1 reference

14 August 2017

Lee R Mobley

1

1 reference

14 August 2017

Thomas J Hoerger

series ordinal

2

1 reference

14 August 2017

John S Wittenborn

series ordinal

3

1 reference

14 August 2017

Jaya K Rao

series ordinal

5

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

Medical Decision Making

1 reference

14 August 2017

26

1 reference

14 August 2017

2

1 reference

14 August 2017

194-206

1 reference

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

Poststroke rehabilitation in older Americans. The Medicare experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

What is the price of life and why doesn't it increase at the rate of inflation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X06286478

21 January 2018

Identifiers

DOI

10.1177/0272989X06286478

1 reference

release_a6tw7pw55nek3a2ffkz57yxhou

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/a6tw7pw55nek3a2ffkz57yxhou

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference